UPL Limited, a global leader in sustainable agriculture solutions, has been honored with the Clarivate South Asia Innovation ...

Uveal melanoma data from the Phase 1b trial that support the Phase 2 cohort will be presented by Sapna Patel, MD, in a proffered paper presentation at the European Society for Medical Oncology (ESMO) ...

With a low price-to-earnings multiple and a significant presence in Seth Klarman’s investment portfolio, Clarivate Plc ...

Seth Klarman, one of the most esteemed figures in value investing, has achieved success through his steadfast commitment to holding investments for the long term, allowing intrinsic value to be fully ...

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the winners of the ...

Disruptions in daily light cycles can throw tea plants' internal rhythms into disarray—undermining their ability to ...

UPL continues to invest in breakthrough technologies, digital platforms, and collaborative research to address global food ...

A new analysis has uncovered strategies, including fabricated research and paid authorships and citations, by which organised scientific fraud is increasing and undermining the integrity of science at ...

Clarivate is a turnaround story with a strong recurring revenue base but faces integration issues, high debt, and negative ...

New study warns of pervasive scientific fraud, revealing organized actors behind industrialized academic misconduct worldwide ...

Companies that broker and facilitate scientific fraud are large, resilient, and growing rapidly, according to a new study.

We came across a bullish thesis on Clarivate Plc on Valueinvestorsclub.com by sediment. In this article, we will summarize ...